Higher IL-2 expression generated by the interaction of CD40 ligand and CD40 between T cells and macrophages with CSF1R c.1085 genotype A_G is the potential mechanism explaining why CRC patients with this germline variant had a better clinical outcome. The gene discussed is CD40; the disease is colorectal carcinoma.